Hansa Biopharma AB (publ) (STO:HNSA)
Sweden · Delayed Price · Currency is SEK 31.68
+0.32 (1.02%)
Jun 4, 2026, 5:29 PM CET
Hansa Biopharma AB Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Hansa Biopharma AB stock has a consensus rating of "Strong Buy" and an average price target of kr 75.71. The average 1-year stock price forecast is 138.98% higher than the current stock price, while the lowest is kr 35.00 (+10.48%) and the highest is kr 103.00 (+225.13%).
Price Target: kr 75.71 (+138.98%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Hansa Biopharma AB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates kr 103.00 | Buy | Reiterates | kr 103.00 | +225.13% | May 20, 2026 |
| Wedbush | Wedbush | Buy Initiates kr 69.00 | Buy | Initiates | kr 69.00 | +117.80% | Jan 7, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.